Solid Tumors That Overexpress HER2 (HER2 Positive) Clinical Trials

Solid Tumors That Overexpress HER2 (HER2 Positive)

Explore clinical trials studying Solid Tumors That Overexpress HER2 (HER2 Positive). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Solid Tumors That Overexpress HER2 (HER2 Positive) trial results

Completed

Phase 1, Multiple Ascending Dose Study of Anti-HER2 FCAB FS102 in HER2 Positive Solid Tumors (Anti HER2 Fcab)

NCT02286219

Conditions: Solid Tumors That Overexpress HER2 (HER2 Positive)
Locations: Anthony El-Khoueiry, Md Los Angeles, California, United States

MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States

The West Clinic Memphis, Tennessee, United States

Southwest Texas Addiction Research And Tech (Start) Center San Antonio, Texas, United States

View Trial Details